AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06100770 — intervention group
Intervention type: DEVICE
Intervention: Single-chamber atrial transvenous pacemaker
Description: This study will utilize real-world data from patients implanted with a single-chamber atrial transvenous pacemaker as a comparator to the Aveir AR LP study arm. No device intervention is required in this study
Study NCT04396379 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Implant an epicardial device to reshape the mitral valve annulus
Description: The implant is intended to epicardially reshape the mitral valve annulus and left ventricle without the need for cardiopulmonary bypass (CPB) and open-heart access (atriotomy), in patients with left ventricular dilation and mitral valve insufficiency in patients with ischemic or functional MR.
Study NCT04979533 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Insufflator oxygen tubing
Description: high flow, low pressure oxygen with pressure relief valve and luer Lock connections delivered at 15 L/min through surgeon's laryngoscope.
Study NCT05175196 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: CandyCollect
Description: The CandyCollect device is a novel, micro-engineered, lollipop-inspired platform. It has functionalized open microchannels for pathogen capture and concentration. It also has time-controlled flavoring release to make the platform more patient-centric.
Study NCT05175196 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Lollipop Swab
Description: The lollipop swab is a typical swab that would be used to obtain routine pharyngeal samples. Child participants are instructed to suck on the swab for 10 seconds, as they would suck on a lollipop. Participant will be asked to take this test twice.
Study NCT05315648 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: anesthesia approach (general anesthesia or non-general anesthesia)
Description: patients in group GA received general anesthesia followed with FNB. patients in group NGA received CSEA followed with FNB
Study NCT05601180 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Respicure®
Description: Respicure® is an inhalation solution that contains two natural extracts: quercetin and resveratrol in a concentration of 0.38%/0.38%.
Study NCT05601180 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of care
Description: standard treatment is prescribed by the treating physician.
Study NCT05023070 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cannabidiol
Description: Cannabidiol 200 mg
Study NCT05023070 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cannabidiol
Description: Cannabidiol 400 mg
Study NCT05023070 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cannabidiol
Description: Epidiolex 400 mg
Study NCT06351085 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Pre-Visit Planner
Description: The study is comparing the implementation of a Pre-Visit Planner to go through the shared decision making process.
Study NCT06351085 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Pre-Visit Planner + MyChart
Description: The study is comparing the implementation of a Pre-Visit Planner to go through the shared decision making process as well as testing if watching educational videos about the Lung Cancer Screening (LCS) process prior to talking to an LVN will help with LCS uptake.
Study NCT05301582 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Tidal volume challenge test
Description: The purpose of our study is to verify the predictability of TVC test during laparoscopic abdominal surgery for early postoperative AKI and intra-operative hypotension.
Study NCT05937620 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: 99mTC nanocolloid albumin injection
Description: All patients will receive an injection of both tracers in order to detect the sentinel lymph node
Study NCT05937620 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: ICG injection
Description: All patients will receive an injection of both tracers in order to detect the sentinel lymph node
Study NCT06349707 — intervention group
Intervention type: OTHER
Intervention: other: Observational
Description: For 18 ICU patients, retrospective collection of routine bioclinical database (ICCA db)
Study NCT05667506 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: single dose of CNCT19
Description: Autologous 2nd generation CD19-directed CAR-T cells, single infusion intravenously.~Lymphodepletion treatment:~Drugs:Fludarabine Drugs: Cyclophosphamide
Study NCT05205200 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-1316
Description: PD-L1 antibody
Study NCT05205200 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: SHR-1316
Description: PD-L1 antibody
Study NCT05205200 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR6390
Description: CDK4/6 inhibitor
Study NCT05205200 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: SHR6390
Description: CDK4/6 inhibitor
Study NCT05205200 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab paclitaxel
Description: Albumin bound paclitaxel
Study NCT05205200 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nab paclitaxel
Description: Albumin bound paclitaxel
Study NCT05205200 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SERD
Description: Fulvestrant
Study NCT05205200 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: SERD
Description: Fulvestrant
Study NCT05205200 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: SERD
Description: Fulvestrant
Study NCT05205200 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AI
Description: aromatase inhibitor
Study NCT05205200 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: AI
Description: aromatase inhibitor
Study NCT04653259 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: LYFE MD app
Description: LyfeMD app is a digital health platform for patients living with both Crohn's disease (CD) and Ulcerative colitis (UC). LyfeMD is meant to help people live and thrive while managing their inflammatory disease with holistic, easy-to-implement, evidence based lifestyle therapies. LyfeMD is one app with multiple features - ranging from customized diet using anti-inflammatory principles identified from recent research, exercise plans to mindfulness and stress reduction programs. It helps patients make therapeutic diet choices to treat inflammation and provides stress reduction strategies when they feel unwell. The LyfeMD app also supports patients to maintain remission even when they're feeling well with trusted resources designed to keep them symptom free.~In addition to delivering personalized and interactive support, the app uses behaviour science to help patients change their habits, improve their health and reduce the burden IBD places on their lives.
Study NCT06195176 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Shoulder exercises
Description: Operational Definition:~* Lift the shoulders as high as possible toward the ears.~* Maintain this position for 3 seconds.~* Rest.~* Repeat 10 times at the beginning of each hour during the immediate postoperative period on the hospital ward.~* Suspend during the night.
Study NCT06195176 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Hand exercises
Description: Operational Definition:~* Open and close the hands, making a fist and applying force.~* Maintain this position for 3 seconds.~* Rest.~* Repeat 10 times at the beginning of each hour during the immediate postoperative period on the hospital ward.~* Suspend during the night.
Study NCT05064579 — intervention group
Intervention type: OTHER
Intervention: Questionnaires
Description: Questionnaire in two parts: one part on the objectives related to taking the treatment and the objectives related to the treatment modality and a second part on the general characteristics of each participant and the characteristics of the child's asthma.
Study NCT06052514 — intervention group
Intervention type: DEVICE
Intervention: Continuous positive airway pressure
Description: Patients with moderate or severe OSA will be treated with CPAP
Study NCT06215209 — intervention group
Intervention type: OTHER
Intervention: position
Description: patients will be in supine position and prone position
Study NCT04551768 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 50 mg/mL Virazole
Description: 50 mg/mL Virazole aerosolized and administered over 1 hour twice a day for up to 6 days.
Study NCT04551768 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 100 mg/mL Virazole
Description: 100 mg/mL Virazole aerosolized and administered over 30 minutes twice a day for up to 6 days.
Study NCT05028205 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Prevention Plus
Description: Families will receive a behavioral intervention for childhood obesity provided by a BHC. This will consist of three, in-person meetings (months 1, 3, and 5), and three, 20-minute phone calls (months 2,4, and 6). During in-person visits, child height and weight will be taken, and BMI will be plotted on the BMI-for-age growth chart. During these sessions, families will receive feedback on child growth and weight status. Prevention Plus materials and child and caregiver energy balance behavior goals will be reviewed. The phone calls will be with the caregiver, where caregivers will be asked to measure the height and weight of their child, calculate BMI, and plot on the BMI-for-age growth chart. The BHC will discuss the family's progress on achieving child and caregiver goals and implementation of behavioral parenting strategies. Families will receive a fruit and vegetable prescription (FVx) in addition to the standard Prevention Plus family-based behavioral weight loss treatment.
Study NCT05530356 — intervention group
Intervention type: DRUG
Intervention: Aminohippurate Sodium Inj 20%
Description: Diagnostic aid/agent used to measure effective renal plasma flow (ERPF)
Study NCT05530356 — intervention group
Intervention type: DRUG
Intervention: Iohexol Inj 300 MG/ML
Description: Diagnostic aid/agent used to measure glomerular filtration rate (GFR)
Study NCT05530356 — intervention group
Intervention type: DRUG
Intervention: Dextran 40
Description: Diagnostic aid/agent used to measure glomerular size selectivity
Study NCT05530356 — intervention group
Intervention type: PROCEDURE
Intervention: Renal Biopsy
Description: Minimally invasive outpatient procedure in interventional radiology to obtain renal tissue cores.
Study NCT05530356 — intervention group
Intervention type: RADIATION
Intervention: Positron Emission Tomography
Description: Imaging study performed to study renal oxidative metabolism
Study NCT05306886 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ICB Medical Insoles
Description: After the foot analysis of the participants in the intervention group, special insoles will be designed in a computer program. In these insoles, 3-6 mm medial wedge support, 1-3 mm heel wedge support, 2-4 mm medial longitudinal arch support will be provided. These values will be determined according to the needs of each participant. A single physiotherapist will design all insoles. All drawings will be made by a single physiotherapist. After the design of the insoles is completed, insoles will be produced by transferring them to a Computer Numerical Control (CNC) machine. Ethyl vinyl acetate (EVA), the use of which has been found useful before, will be used as the material in the insoles molds. After processing, 1mm thick fabric will be used for the top coating. All insoles will be produced by the same physiotherapist.
Study NCT05306886 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: ICM Insoles
Description: As in the intervention group, insoles will be designed for the participants in the control group, processed by CNC machine and the production will be completed. Only 2mm medial longitudinal arch support will be given to the insoles of the people in this group.
Study NCT05926869 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clindamycin and Dapsone gel for 03 months
Description: Clindamycin is a topical antibiotic which has been widely used in treatment of acne for many decades. Topical Dapsone 5% gel contains sulfone and has an advanced solvent micro particulate delivery system that enables penetration of stratum corneum . It is a new topical drug used in the treatment of Moderate Acne Vulgaris. It has antibacterial as well as anti inflammatory effects
Study NCT05295199 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Progressive relaxation exercise
Description: Progressive relaxation exercise is a type of exercise that involves voluntary stretching and relaxation of major muscle groups in the human body, from the hands to the feet.
Study NCT04617405 — intervention group
Intervention type: OTHER
Intervention: No interventions
Description: No interventions
Study NCT05658653 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Educational Materials for Chronic Disease Management Test (CDMT)
Description: These materials detail what the test does, how it is used, the validity and specifications of the test, and how to read its test report.
Study NCT04765878 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: RespirAq Humidification
Description: Humidifier
Study NCT05707897 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TS-142 10 mg
Description: Single-dose of 10 mg of TS-142
Study NCT05317442 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fespixon Cream
Description: 1. Name: Fespixon Cream~2. Dosage form: Topical cream, 15 g ointment per tube~3. Active ingredients: 1.25% extracts of Plectranthus amboinicus (PA-F4, 0.25%) and Centella asiatica (S1, 1%)~4. Dose(s): Apply 1 cc per 5 cm\^2 ulcer size (not exceeding 2 mm in thickness)~5. Dosing schedule: Apply once a day~6. Duration: up to 16 weeks
Study NCT04953962 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CBP501 (16)
Description: 16 mg/m2
Study NCT04953962 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CBP501 (25)
Description: 25 mg/m2
Study NCT05899790 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: VR
Description: The first interview with the patients in the intervention group will be held in the afternoon, the day before the surgery. After completing the forms and scale the video containing information about the operating room environment will be applied to the patients through SG glasses and headphones.~Before the surgical intervention, patients admitted to the pre-operative waiting area from the clinic, the video containing information about the operating room environment will be watched by the patients through SG glasses and headphones.
Study NCT05420051 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Positive Psychology + Motivational Interviewing
Description: The 8-week PP-MI intervention focuses on enhancing well-being (through PP) and increasing physical activity (through MI). Each week, participants will complete a PP activity and work towards a physical activity goal, then complete a phone session with a study trainer. The PP portion of the program will focus on the cultivation of well-being through the performance of easy-to complete activities (e.g., using a strength in a new way) and review of the positive feelings they generate. The MI portion of the program will focus on assisting participants to improve physical activity levels, resolve ambivalence to behavior change, set realistic physical activity goals, problem-solve barriers, and identify resources to complete behavior change. Finally, participants will receive twice weekly text messages (for 16 weeks) to encourage completion of PP activities and engagement in physical activity.
Study NCT05420051 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Motivational Interviewing
Description: The 8-week MI-alone intervention focuses on providing education and enhancing motivation to engage in health behaviors (through MI). Each week, participants will complete an activity related to a health behavior (e.g., consider the pros and cons of behavior change, set a health behavior goal), then complete a phone session with a study trainer. This program will focus on assisting participants to improve health behavior adherence (including physical activity), resolve ambivalence to behavior change, set realistic health behavior goals, problem-solve barriers, and identify resources to complete behavior change. Additional time in MI-alone phone sessions will be spent on review of core MI skills, problem-solving of barriers, and discussion of resources. Finally, participants will receive twice weekly text messages (for 16 weeks) to encourage engagement in health behaviors.
Study NCT05764122 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BIIB131
Description: Administered as specified in the treatment arm.
Study NCT05764122 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered as specified in the treatment arm.
Study NCT06263322 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Actionable remotely generated health data
Description: Remotely captured, patient generated health data will be used to inform provider care following re-vascular surgery in patients with chronic limb threatening ischemia
Study NCT06263322 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Non-Actionable remotely generated health data
Description: Remotely captured, patient generated health data is captured, but will not be used to inform provider care following re-vascular surgery in patients with chronic limb threatening ischemia
Study NCT04963426 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral interventions targeting multiple risk behaviors as well as protective factors
Description: Depending on the baseline data and prioritization of actions, behavioral interventions related to the following topics will be implemented: alcohol use, dietary behaviors, drug use, hygiene, mental health, physical activity, protective factors, sexual behaviors, tobacco use, violence and unintentional injury.
Study NCT04963426 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: School-level interventions targeting the school environment and system
Description: Depending on the baseline data and prioritization of actions, and based on the Global Standards for Health Promoting Schools, school-level interventions related to the following will be implemented: school policies and resources, school governance and leadership, school and community partnerships, school curriculum, school social-emotional environment, school physical environment, school health services
Study NCT05997407 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Organic Conceptions mindset management program
Description: Organic Conceptions is a theoretical model and corresponding 9-step cognitive-based therapy program that enables people to understand where they are in their fertility journey, and provides them with coping strategies to reframe the painful emotional side effects of infertility. In addition to the 9-step program, there are mini-classes on the key triggers that people face when dealing with infertility.~The intervention consists of a series of assignments that participants in the intervention group will complete for a ten-week period. These assignments will take approximately three hours per week to complete. In addition, participants will complete biweekly live support group sessions led by certified coaches and will have the option to join a Facebook support group.
Study NCT05214742 — intervention group
Intervention type: OTHER
Intervention: Diagnostic Test
Description: Molecular diagnosis carried out in the context of care
Study NCT04809181 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azacitidine in Combination With Venetoclax
Description: Azacitidine in combination with venetoclax
Study NCT04668443 — intervention group
Intervention type: OTHER
Intervention: Graphical Informed Consent (GIC)
Description: The GIC (set of illustrations that complement the written information and consent form) will be proposed to prospective participants by researchers, systematically during the pre-test (stage 1). If the stage 1 shows no negative impact of the GIC on the consent process, the stage 2 will be implemented and the GIC will be proposed by researchers when they feel it could be beneficial for the participant.
Study NCT04953962 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: 60mg/m2
Study NCT04953962 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: 240 mg
Study NCT05444946 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone tablet and Itraconazole
Description: Oral prednisolone 0.5 mg/Kg body weight tapered over 4 months and oral itraconazole (400 mg/day). The dose of itraconazole will be adjusted according to therapeutic drug monitoring to achieve a serum trough level of 0.5 microgram/mL. traconazole will be given for 12 months
Study NCT05444946 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oral itraconazole
Description: Oral itraconazole (400 mg/day). The dose of itraconazole will be adjusted according to therapeutic drug monitoring to achieve a serum trough level of 0.5 microgram/mL. Itraconazole will be given for 12 months
Study NCT06517238 — intervention group
Intervention type: OTHER
Intervention: There is no intervention
Description: Observal Study.There is no intervention
Study NCT04016012 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Local Zambian Foods
Description: Each week, participants in the intervention group will collect a pack of foodstuffs to last a week from the research site. The packs will be adjusted according to the weight of the participant and daily recommended allowances. Packaging of foodstuffs will be done in the food service lab at the Mukuba University. Instructions on how to prepare and use the food will be given to the participants. All food Items will be labelled diabetic food to avoid intra-household sharing.
Study NCT05323019 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Psychotherapy
Description: Participants will receive 8 remote therapy sessions conducted via phone or video, Therapy sessions consists of modules selected using a shared decision making process, tailored so that it is personally meaningful to each participant. Participants will also receive supportive text messages on selected days during the 28 day study.